Explore our comprehensive portfolio that addresses the complete care continuum for many of the world’s most threatening diseases. 

Discover the stories of pioneers pushing the boundaries of what’s possible in healthcare to help improve people’s lives around the world.

Patient-centered innovation has been and always will be at the core of our company. Dive deeper into our fascinating technologies.

We pioneer breakthroughs in healthcare. For everyone. Everywhere. Sustainably. Learn more about our purpose, our innovation leadership, our culture, and our strategy.

  1. Home

  2. Press center
  3. Press releases
  4. Siemens Healthineers successfully closes 2025 fiscal year in challenging environment
Press release

Siemens Healthineers successfully closes 2025 fiscal year in challenging environment

Siemens Healthineers AG today announces its results for the fourth quarter of fiscal year 2025 ended September 30, 2025, and the full fiscal year 2025.
Published on November 5, 2025

Fiscal Year 2025 

  • Very good equipment book-to-bill ratio of 1.14 
  • Strong comparable revenue growth of 5.9% 
  • Adjusted EBIT margin of 16.5%, 0.8 percentage points above prior year despite higher tariffs; adjusted EBIT up to just under €3.9 billion 
  • Adjusted basic earnings per share of €2.39 
  • Free cash flow of around €2.7 billion, clearly above prior year 
  • Proposed dividend of €1.00 per share (prior year: €0.95)

Q4 Fiscal Year 2025

  • Very good equipment book-to-bill ratio of 1.12 
  • Comparable revenue growth of 3.7% 
  • Imaging comparable revenue growth of 6.5%; adjusted EBIT margin of 20.6% 
  • Diagnostics comparable revenue flat (-0.3%); adjusted EBIT margin of 7.5% 
  • Varian comparable revenue up 1.4% against very strong prior-year quarters; adjusted EBIT margin of 19.7% 
  • Advanced Therapies comparable revenue growth of 3.8%; adjusted EBIT margin of 17.5% 
  • Overall adjusted EBIT margin of 17.4%, slightly under the prior-year quarter due to higher tariffs 
  • Free cash flow of around €860 million 
  • Adjusted basic earnings per share of €0.68, slightly above prior-year quarter

Outlook for Fiscal Year 2026

For fiscal year 2026, we expect comparable revenue growth of between 5% to 6% compared with fiscal year 2025. We expect adjusted basic earnings per share to be between €2.20 and €2.40. 

Bernd Montag, CEO of Siemens Healthineers AG:

”We have closed another successful year, despite a challenging environment. Following this achievement, we are raising our proposed dividend. We have a solid foundation for our next strategy phase.“

Download Quarterly Statement(pdf, 284.61 KB)

Siemens Healthineers 2026

Siemens Healthineers pioneers breakthroughs in healthcare. For everyone. Everywhere. Sustainably. The company is a global provider of healthcare equipment, solutions and services, with activities in more than 180 countries and direct representation in more than 70. The group comprises Siemens Healthineers AG, listed as SHL in Frankfurt, Germany, and its subsidiaries. As a leading medical technology company, Siemens Healthineers is committed to improving access to healthcare for underserved communities worldwide and is striving to overcome the most threatening diseases. The company is principally active in the areas of imaging, diagnostics, cancer care and minimally invasive therapies, augmented by digital technology and artificial intelligence. In fiscal 2025, which ended on September 30, 2025, Siemens Healthineers had approximately 74,000 employees worldwide and generated revenue of around €23.4 billion. Further information is available at siemens-healthineers.com.